These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 5171223)

  • 1. New cancerostatics developed in Czechoslovakia. Introductory lecture.
    Semonský M
    Neoplasma; 1971; 18(5):431-4. PubMed ID: 5171223
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of a new bifunctional alkylating agent (PTT-119) on in vitro growth of human cell lines and normal myeloid progenitors (CFU-GM).
    Lemoli RM; Visani G; Tosi P; Mazza P; Motta MR; Rizzi S; Zinzani PL; Poluzzi C; Gherlinzoni F; Tura S
    Haematologica; 1988; 73(3):195-200. PubMed ID: 3139515
    [No Abstract]   [Full Text] [Related]  

  • 3. Contribution to elucidation of biochemical action mechanism of Cytembena.
    Slavíková V; Semonský M; Slavík K; Zikán V; Bloch A; Veselá H
    Neoplasma; 1971; 18(5):455-7. PubMed ID: 5119518
    [No Abstract]   [Full Text] [Related]  

  • 4. Synthesis and anticancer activity of 5-diethylaminomethyl derivatives and nitrogen mustards of uracil and 2-thiouracils.
    Fabrissin S; de Nardo M; Nisi C; Morasca L; Dolfini E; Franchi G
    J Med Chem; 1976 May; 19(5):639-42. PubMed ID: 1271405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The mechanisms of action of antitumor compounds.
    Belousova AK
    Natl Cancer Inst Monogr; 1977 Mar; (45):183-93. PubMed ID: 73135
    [No Abstract]   [Full Text] [Related]  

  • 6. Cytembena administered in combination with cyclophosphamide in Yoshida ascitic sarcoma.
    Veselá H; Jelínek V; Pujman V; Zlatkovská Z
    Neoplasma; 1971; 18(5):459-64. PubMed ID: 5119519
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of cytostatics on the uterotrophic action of estrogens.
    Jelínek V; Rezábek K
    Neoplasma; 1969; 16(2):133-6. PubMed ID: 5820142
    [No Abstract]   [Full Text] [Related]  

  • 8. Antitumor and mutagenic properties of a variety of heterocyclic nitrogen and sulfur mustards.
    Creech HJ; Preston RK; Peck RM; O'Connell AP
    J Med Chem; 1972 Jul; 15(7):739-46. PubMed ID: 4557857
    [No Abstract]   [Full Text] [Related]  

  • 9. Influence of the chemical structure on the biological tendency of cytostatic compounds related to dibromomanitol. II. Mechanism of action.
    Horváth IP; Institóris L
    Arzneimittelforschung; 1967 Feb; 17(2):149-55. PubMed ID: 5631482
    [No Abstract]   [Full Text] [Related]  

  • 10. Synthesis and biological evaluation of 6-ethynyluracil, a thiol-specific alkylating pyrimidine.
    Schroeder AC; Bloch A; Perman JL; Bobek M
    J Med Chem; 1982 Oct; 25(10):1255-8. PubMed ID: 7143368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromosome aberrations induced in human leukocytes by the antitumour multipeptide compound "peptichemio". A light and electronmicroscopic study.
    Ruzicka F; Nowotny H
    Mikroskopie; 1973 Dec; 29(11):325-30. PubMed ID: 4777005
    [No Abstract]   [Full Text] [Related]  

  • 12. Cytembena treatment of advanced gynaecological carcinomas.
    Dvorák O
    Neoplasma; 1971; 18(5):461-4. PubMed ID: 5119520
    [No Abstract]   [Full Text] [Related]  

  • 13. Anticancer activities of 2,3-dihydro-1,4-benzothiazines, and of their 4-(N-alkyl amides) and 4-(N-alkyl N-nitrosoamides).
    Gupta RR; Dev PK; Sharma ML; Rajoria CM; Gupta A; Nyati M
    Anticancer Drugs; 1993 Oct; 4(5):589-92. PubMed ID: 8292818
    [No Abstract]   [Full Text] [Related]  

  • 14. Substances with antineoplastic effect. XL. The influence of sodium salt of beta-4-methoxybenzoyl-beta-bromacrylic acid (MBBA) and some related substances on the respiration of rat liver homogenate and Yoshida ascites rat sarcoma cells; the influence of these substances on the mechanisms of oxidative phosphorylation of the liver homogenate.
    Helia O; Jindra A; Semonský M
    Neoplasma; 1969; 16(6):597-604. PubMed ID: 5369025
    [No Abstract]   [Full Text] [Related]  

  • 15. [Progress in the field of drug development. 6].
    Koch H; Mayr E; Richter J; Selchau M
    Pharmazie; 1973; 28(11):691-713. PubMed ID: 4151594
    [No Abstract]   [Full Text] [Related]  

  • 16. [Antineoplastic agents. 44. Nuclear substituted beta-benzoyl-beta-brom(chlor)acryl acids and beta-4-methoxybenzoyl-alpha-bromacryl acid].
    Semonský M; Zikán V; Vrba L; Jelínek V; Slavíková V; Slavík K; Kakác B
    Pharmazie; 1971 May; 26(5):286-91. PubMed ID: 5563060
    [No Abstract]   [Full Text] [Related]  

  • 17. The influence of alkylants, antimetabolites and chloroquine on oxydative biotransformation reactions and on the excretion of ascorbic acid in the rat.
    Traeger A; Bauer B; Klinger W; Ankermann H
    Acta Biol Med Ger; 1973; 30(3):423-34. PubMed ID: 4800889
    [No Abstract]   [Full Text] [Related]  

  • 18. A mitomycin C-resistant Jensen rat sarcoma: chemotherapy studies.
    Sugiura K; Merker PC
    Cancer Res; 1963 Sep; 23(8 Pt 2):1475-82. PubMed ID: 5878213
    [No Abstract]   [Full Text] [Related]  

  • 19. [The influence of some alkylating antiblastic drugs and antimetabolites on the healing process of fracture foci. (Experimental research)].
    Mangione F; Taverna L
    Boll Soc Ital Biol Sper; 1964 Dec; 40(24):1711-2. PubMed ID: 5877911
    [No Abstract]   [Full Text] [Related]  

  • 20. Structure-activity relationship of a series of nitrogen mustard- and pyrrole-containing minor groove-binding agents related to distamycin.
    Wyatt MD; Garbiras BJ; Haskell MK; Lee M; Souhami RL; Hartley JA
    Anticancer Drug Des; 1994 Dec; 9(6):511-25. PubMed ID: 7880376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.